全球药物滥用测试市场规模、份额、成长分析（按药物、按样本）- 2024-2031 年产业预测

Global Drug of Abuse Testing Market Size, Share, Growth Analysis, By Drug(Alcohol, Cocaine), By Sample(Urine, Saliva) - Industry Forecast 2024-2031

出版日期: 2024年03月05日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球滥用药物检测市场规模将为67亿美元，预测期间（2024-2031年）复合年增长率为6.3%，从2023年的71.2亿美元成长至116.1亿美元。

由于药物滥用现像日益普遍、行业中对药物检测的严格监管以及人们对医疗保健和职场环境中药物检测重要性的认识不断提高等因素，全球药物滥用检测市场正在显着增长。该市场是由对检测和预防药物滥用的药物检测服务不断增长的需求推动的，根据联合国毒品犯罪防制署的《世界毒品报告》，该市场约有 2.55 亿使用者。事实确实如此。政府提高药物检测意识和组织合规性的措施也有助于市场扩张。然而，也存在一些挑战，例如测试产品无法准确检测少量的某些药物，以及偏好和非法药物使用合法化的法律变化对市场需求的影响。儘管面临挑战，免疫检测、层析法和分子诊断等测试技术的进步提高了测试的灵敏度、特异性和准确性，为市场提供了成长机会。药物检测与其他医疗保健服务的整合以及口腔液检测需求的增加也进一步推动了市场的成长。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争形势

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Alere Inc.（US）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）
Premier Biotech Inc.（US）

简介目录

Product Code: SQMIG30A2015

Global Drug of Abuse Testing Market size was valued at USD 6.7 Billion in 2022 and is poised to grow from USD 7.12 Billion in 2023 to USD 11.61 Billion by 2031, at a CAGR of 6.3% during the forecast period (2024- 2031).

The global drug of abuse testing market is witnessing significant growth driven by factors such as the increasing prevalence of substance abuse, stringent regulations for drug testing in industries, and growing awareness about drug testing's importance in healthcare and workplace settings. The market is propelled by rising demand for drug testing services to detect and prevent substance abuse, with approximately 255 million users reported in the World Drug Report by the United Nations Office on Drugs and Crime. Government initiatives promoting awareness and organizational compliance for drug testing also contribute to market expansion. However, challenges include the inability of testing products to detect small amounts of certain drugs accurately and the impact of changing laws legalizing recreational or illicit drug use on market demand. Despite challenges, the market offers growth opportunities driven by technological advancements in testing technologies like immunoassays, chromatography, and molecular diagnostics, enhancing testing sensitivity, specificity, and accuracy. Integration of drug testing with other healthcare services and increasing demand for oral fluid testing further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segmental Analysis

The global drug abuse testing market is segmented on the basis of drug, sample, and region. By drug, the market is segmented into alcohol, cocaine, marijuana/cannabis, LSD, opioids, and others. By sample, the market is segmented into Urine, Saliva, Blood, Hair, Breath, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug of Abuse Testing Market

The growing production, consumption, and trade of both new and illicit drugs are expected to drive the demand for Drug of Abuse (DoA) testing, thus fueling the industry's growth. According to the United Nations Office on Drugs and Crime's World Drug Report 2017, there was an annual prevalence of 5.3% for illicit drug use, with 255 million users in 2015. This significant number of drug users underscores the necessity for DoA testing, which will propel the market forward. Government initiatives aimed at raising awareness about drug abuse and increasing organizational compliance for DoA testing will also contribute to the overall growth of the market. Additionally, there is a high demand for testing products that offer enhanced specificity and sensitivity to detect designer drugs, further bolstering the industry's expansion.

Restraints in the Global Drug of Abuse Testing Market

The growth of the drugs of abuse (DOA) testing market may face restraints due to limitations in current testing products detecting small amounts of specific drugs. Additionally, the transformation of laws to legalize recreational or illicit drugs is expected to pose a challenge during the forecast period of 2024-2031. This report on the DOA testing market provides comprehensive information on recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and local market players, emerging revenue opportunities, changes in market regulations, strategic growth analysis, market size, category market growth, application niches, product approvals, product launches, geographic expansions, and technological innovations. For more detailed information on the DOA testing market, you can contact Data Bridge Market Research for an Analyst Brief, where their team will assist you in making informed decisions to achieve market growth.

Market Trends of the Global Drug of Abuse Testing Market

There is a growing trend towards point-of-care testing, which enables quick and convenient drug testing at the bedside or in non-laboratory settings. This trend is fueled by the demand for rapid results and the capability to perform tests in remote or decentralized locations.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Drug of Abuse Testing Market by Drug

Market Overview
Alcohol
Cocaine
Marijuana/Cannabis
LSD
Opioids
and Others.

Global Drug of Abuse Testing Market by Sample

Market Overview
Urine
Saliva
Blood
Hair
Breath
and Others

Global Drug of Abuse Testing Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alere Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments